Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery.
作者信息
Sousa-Uva Miguel, Storey Robert, Huber Kurt, Falk Volkmar, Leite-Moreira Adelino F, Amour Julien, Al-Attar Nawwar, Ascione Raimondo, Taggart David, Collet Jean-Philippe
机构信息
Department of Cardiac Surgery, Hospital Cruz Vermelha, Lisbon, Portugal Department of Physiology and Cardiothoracic Surgery, Cardiovascular Research Center, Faculty of Medicine, University of Porto, Porto, Portugal.
Department of Cardiovascular Science, University of Sheffield, Sheffield, UK.
出版信息
Eur Heart J. 2014 Jun 14;35(23):1510-4. doi: 10.1093/eurheartj/ehu158. Epub 2014 Apr 18.
Abstract
摘要
相似文献
1
Expert position paper on the management of antiplatelet therapy in patients undergoing coronary artery bypass graft surgery.冠状动脉搭桥手术患者抗血小板治疗管理专家立场文件。
Eur Heart J. 2014 Jun 14;35(23):1510-4. doi: 10.1093/eurheartj/ehu158. Epub 2014 Apr 18.
2
Development and clinical use of prasugrel and ticagrelor.普拉格雷和替格瑞洛的研发与临床应用。
Curr Pharm Des. 2012;18(33):5240-60. doi: 10.2174/138161212803251989.
3
Dual antiplatelet therapy with prasugrel or ticagrelor versus clopidogrel in interventional cardiology.经皮冠状动脉介入治疗中的普拉格雷或替格瑞洛双联抗血小板治疗与氯吡格雷的比较。
Cardiovasc Drugs Ther. 2013 Jun;27(3):239-45. doi: 10.1007/s10557-013-6444-2.
4
Third generation P2Y12 antagonists inhibit platelet aggregation more effectively than clopidogrel in a myocardial infarction registry.第三代 P2Y12 拮抗剂在心肌梗死注册研究中比氯吡格雷更有效地抑制血小板聚集。
Thromb Haemost. 2014 Feb;111(2):266-72. doi: 10.1160/TH13-06-0508. Epub 2013 Oct 31.
5
Comparison of patient intake of ticagrelor, prasugrel, or clopidogrel on restoring platelet function by donor platelets.替格瑞洛、普拉格雷或氯吡格雷对供体血小板恢复血小板功能的患者摄入量比较。
Transfusion. 2015 Jun;55(6):1320-6. doi: 10.1111/trf.12977. Epub 2015 Jan 15.
6
"Conversations in cardiology": How do you pick the best antiplatelet drug--clopidogrel, prasugrel, ticagrelor for your PCI patient?“心脏病学中的对话”：如何为接受经皮冠状动脉介入治疗（PCI）的患者选择最佳抗血小板药物——氯吡格雷、普拉格雷、替格瑞洛？
Catheter Cardiovasc Interv. 2012 Feb 1;79(2):255-62. doi: 10.1002/ccd.24299.
7
Impact of clopidogrel and potent P2Y 12 -inhibitors on mortality and stroke in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: a systematic review and meta-analysis.氯吡格雷和强效 P2Y12 抑制剂对急性冠脉综合征或经皮冠状动脉介入治疗患者的死亡率和卒中的影响：系统评价和荟萃分析。
Thromb Haemost. 2013 Jan;109(1):93-101. doi: 10.1160/TH12-06-0377. Epub 2012 Nov 29.
8
Comparative pharmacokinetics and pharmacodynamics of platelet adenosine diphosphate receptor antagonists and their clinical implications.血小板二磷酸腺苷受体拮抗剂的比较药代动力学和药效学及其临床意义。
Clin Pharmacokinet. 2012 Jul 1;51(7):429-42. doi: 10.2165/11630740-000000000-00000.
9
Prasugrel vs. ticagrelor in acute coronary syndromes: which one to choose?普拉格雷与替格瑞洛在急性冠状动脉综合征中的应用：如何选择？
Wien Klin Wochenschr. 2011 Aug;123(15-16):468-76. doi: 10.1007/s00508-011-0027-7. Epub 2011 Aug 3.
10
[Novel agents in antiplatelet therapy].[抗血小板治疗中的新型药物]
Turk Kardiyol Dern Ars. 2010 Jul;38(5):369-78.
引用本文的文献
1
Antiplatelet therapy after coronary artery bypass surgery: five year follow-up of randomised DACAB trial.冠状动脉旁路手术后的抗血小板治疗：随机 DACAB 试验的 5 年随访。
BMJ. 2024 Jun 11;385:e075707. doi: 10.1136/bmj-2023-075707.
2
Ticagrelor inverse agonist activity at the P2Y receptor is non-reversible versus its endogenous agonist adenosine 5´-diphosphate.替格瑞洛对 P2Y 受体的反向激动剂活性与内源性激动剂腺苷 5´-二磷酸相比是非可逆的。
Br J Pharmacol. 2024 Jan;181(1):21-35. doi: 10.1111/bph.16204. Epub 2023 Sep 1.
3
De-escalation or abbreviation of dual antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention: a Consensus Statement from an international expert panel on coronary thrombosis.急性冠状动脉综合征和经皮冠状动脉介入治疗中双联抗血小板治疗的降级或缩短：来自冠状动脉血栓形成国际专家小组的共识声明。
Nat Rev Cardiol. 2023 Dec;20(12):830-844. doi: 10.1038/s41569-023-00901-2. Epub 2023 Jul 20.
4
Antithrombotic drug removal from whole blood using Haemoadsorption with a porous polymer bead sorbent.使用多孔聚合物珠吸附剂从全血中去除抗血栓药物。
Eur Heart J Cardiovasc Pharmacother. 2022 Dec 2;8(8):847-856. doi: 10.1093/ehjcvp/pvac036.
5
The EHA Research Roadmap: Platelet Disorders.欧洲血液学协会研究路线图：血小板疾病
Hemasphere. 2021 Jun 30;5(7):e601. doi: 10.1097/HS9.0000000000000601. eCollection 2021 Jul.
6
Dual Antiplatelet Therapy with Clopidogrel and Aspirin Versus Aspirin Monotherapy in Patients Undergoing Coronary Artery Bypass Graft Surgery.氯吡格雷和阿司匹林双联抗血小板治疗与阿司匹林单药治疗用于冠状动脉旁路移植术患者。
J Am Heart Assoc. 2021 Jun;10(11):e020413. doi: 10.1161/JAHA.120.020413. Epub 2021 May 15.
7
Bleeding complications after dual antiplatelet therapy with ticagrelor versus dual antiplatelet therapy with clopidogrel-a propensity-matched comparative study of two antiplatelet regimes in off-pump coronary artery bypass grafting.替格瑞洛双联抗血小板治疗与氯吡格雷双联抗血小板治疗后的出血并发症——非体外循环冠状动脉搭桥术中两种抗血小板方案的倾向匹配比较研究
Indian J Thorac Cardiovasc Surg. 2021 Jan;37(1):27-37. doi: 10.1007/s12055-020-01052-6. Epub 2020 Oct 7.
8
Consensus Report on Patient Blood Management in Cardiac Surgery by Turkish Society of Cardiovascular Surgery (TSCVS), Turkish Society of Cardiology (TSC), and Society of Cardio-Vascular-Thoracic Anaesthesia and Intensive Care (SCTAIC).土耳其心血管外科学会（TSCVS）、土耳其心脏病学会（TSC）以及心血管胸科麻醉与重症监护学会（SCTAIC）关于心脏手术患者血液管理的共识报告
Turk Gogus Kalp Damar Cerrahisi Derg. 2019 Oct 23;27(4):429-450. doi: 10.5606/tgkdc.dergisi.2019.01902. eCollection 2019 Oct.
9
Ticagrelor Removal by CytoSorb in Patients Requiring Emergent or Urgent Cardiac Surgery: A UK-Based Cost-Utility Analysis.在需要进行急诊或紧急心脏手术的患者中，CytoSorb清除替格瑞洛的效果：一项基于英国的成本效用分析。
Pharmacoecon Open. 2020 Jun;4(2):307-319. doi: 10.1007/s41669-019-00183-w.
10
Development of a risk score for early saphenous vein graft failure: An individual patient data meta-analysis.开发一种用于早期隐静脉移植物失败的风险评分：一项个体患者数据荟萃分析。
J Thorac Cardiovasc Surg. 2020 Jul;160(1):116-127.e4. doi: 10.1016/j.jtcvs.2019.07.086. Epub 2019 Aug 26.
本文引用的文献
1
Meta-analysis of effect of single versus dual antiplatelet therapy on early patency of bypass conduits after coronary artery bypass grafting.荟萃分析：冠状动脉旁路移植术后，单双联抗血小板治疗对旁路移植物早期通畅率的影响。
Am J Cardiol. 2013 Nov 15;112(10):1576-9. doi: 10.1016/j.amjcard.2013.07.017. Epub 2013 Sep 13.
2
Elderly patients with acute coronary syndromes managed without revascularization: insights into the safety of long-term dual antiplatelet therapy with reduced-dose prasugrel versus standard-dose clopidogrel.未进行血运重建治疗的急性冠状动脉综合征老年患者：探讨长期应用小剂量普拉格雷双联抗血小板治疗与标准剂量氯吡格雷相比的安全性。
Circulation. 2013 Aug 20;128(8):823-33. doi: 10.1161/CIRCULATIONAHA.113.002303. Epub 2013 Jul 12.
3
Dual anti-platelet therapy after coronary artery bypass grafting: is there any benefit? A systematic review and meta-analysis.冠状动脉旁路移植术后的双联抗血小板治疗：有任何益处吗？一项系统评价和荟萃分析。
J Card Surg. 2013 Mar;28(2):109-16. doi: 10.1111/jocs.12074.
4
Effect of platelet inhibition with cangrelor during PCI on ischemic events.PCI 中用坎格瑞洛进行血小板抑制对缺血事件的影响。
N Engl J Med. 2013 Apr 4;368(14):1303-13. doi: 10.1056/NEJMoa1300815. Epub 2013 Mar 10.
5
Switching acute coronary syndrome patients from prasugrel to clopidogrel.将急性冠脉综合征患者从普拉格雷转换为氯吡格雷。
JACC Cardiovasc Interv. 2013 Feb;6(2):158-65. doi: 10.1016/j.jcin.2012.09.012.
6
Bedside monitoring to adjust antiplatelet therapy for coronary stenting.床边监测调整经皮冠状动脉介入治疗术后抗血小板治疗。
N Engl J Med. 2012 Nov 29;367(22):2100-9. doi: 10.1056/NEJMoa1209979. Epub 2012 Nov 4.
7
2012 update to the Society of Thoracic Surgeons guideline on use of antiplatelet drugs in patients having cardiac and noncardiac operations.胸外科医师协会关于心脏及非心脏手术患者抗血小板药物使用指南2012年更新版
Ann Thorac Surg. 2012 Nov;94(5):1761-81. doi: 10.1016/j.athoracsur.2012.07.086.
8
Factors contributing to the lower mortality with ticagrelor compared with clopidogrel in patients undergoing coronary artery bypass surgery.导致行经冠状动脉旁路移植术的患者使用替格瑞洛较氯吡格雷死亡率更低的因素。
J Am Coll Cardiol. 2012 Oct 23;60(17):1623-30. doi: 10.1016/j.jacc.2012.07.021. Epub 2012 Sep 26.
9
Aspirin plus clopidogrel for optimal platelet inhibition following off-pump coronary artery bypass surgery: results from the CRYSSA (prevention of Coronary arteRY bypaSS occlusion After off-pump procedures) randomised study.阿司匹林联合氯吡格雷在非体外循环冠状动脉旁路移植术后的最佳血小板抑制作用：CRYSSA（非体外循环手术后冠状动脉旁路阻塞的预防）随机研究结果。
Heart. 2012 Dec;98(23):1710-5. doi: 10.1136/heartjnl-2012-302449. Epub 2012 Sep 2.
10
ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation.ST段抬高型急性心肌梗死患者管理的欧洲心脏病学会指南
Eur Heart J. 2012 Oct;33(20):2569-619. doi: 10.1093/eurheartj/ehs215. Epub 2012 Aug 24.
Zotero 插件